-       Report 
- October 2025
-  198 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  144 Pages 
- Global 
   From       €3155EUR$3,528USD£2,775GBP 
      €3712EUR$4,150USD£3,265GBP 
            -       Report 
- August 2025
-  182 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- May 2025
-  150 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
            -       Report 
- October 2025
-  193 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
             -       Report 
- August 2025
-  197 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- November 2025
-  279 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  390 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  289 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- April 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- April 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Clinical Trials 
- April 2025
-  80 Pages 
- Global 
   From       €1431EUR$1,600USD£1,259GBP 
      €1789EUR$2,000USD£1,574GBP 
            -       Clinical Trials 
- April 2025
-  40 Pages 
- Global 
   From       €894EUR$1,000USD£787GBP 
      €1118EUR$1,250USD£983GBP 
          -       Report 
- July 2025
-  350 Pages 
- Global 
   From       €4427EUR$4,949USD£3,894GBP 
          -       Report 
- July 2025
-  350 Pages 
- Global 
   From       €4427EUR$4,949USD£3,894GBP 
          -       Report 
- June 2025
-  200 Pages 
- Global 
   From       €2495EUR$2,789USD£2,194GBP 
          -       Report 
- May 2025
-  93 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
       
      Colchicine is a medication used to treat and prevent gout and other inflammatory conditions. It is a member of the cardiovascular drug class, which includes drugs used to treat and prevent heart and blood vessel diseases. Colchicine works by reducing inflammation and swelling, and is often used to treat acute gout attacks. It is also used to treat familial Mediterranean fever, pericarditis, and Behcet's disease.
Colchicine is available in both oral and injectable forms, and is typically taken once    or twice a day. Common side effects include nausea, vomiting, and diarrhea. Serious side effects include liver damage, kidney failure, and bone marrow suppression.
The colchicine market is highly competitive, with many generic and branded products available. Companies in the market include Mylan, Teva Pharmaceuticals, Sandoz, and Sun Pharmaceuticals. Show Less   Read more